Vijayasteltar Belsamma Liju (Vijayastelar B Liju)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Radiation Therapy

Sentinel Lymph Node

Tyrosine Kinase

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Sankar Jagadeeshan, Manu Prasad, Mai Badarni, Talal Ben Lulu, Vijayasteltar Belsamma Liju, Sooraj Mathukkada, Claire J Saunders, Avital Beeri Shnerb, Jonathan Zorea, Ksenia M Yegodayev, Monica Wainer, Liza Vtorov, Irit Allon, Ofir Cohen, Gro Gausdal, Dinorah Friedmann-Morvinski, Sok Ching Cheong, Alan L Ho, Ari J Rosenberg, Linda Kessler, Francis Burrows, Dexin Kong, Jennifer R Grandis, Jorge Silvio Gutkind, Moshe Elkabets
Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer. Cancer research (2023)
Aswathy R Devan, Bhagyalakshmi Nair, Kanjoormana Aryan Manu, Vijayasteltar Belsamma Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R Nath
Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 15 (10) (2023)
Divya Ram Jayaram, Sigal Frost, Chanan Argov, Vijayasteltar Belsamma Liju, Nikhil Ponnoor Anto, Amitha Muraleedharan, Assaf Ben-Ari, Rose Sinay, Ilan Smoly, Ofra Novoplansky, Noah Isakov, Debra Toiber, Chen Keasar, Moshe Elkabets, Esti Yeger-Lotem, Etta Livneh
Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs. Proceedings of the National Academy of Sciences of the United States of America 118 (40) (2021)